Inventor

TOKARSKI JOHN S

US36 patents

⚠️ This page may combine multiple inventors who share the name “TOKARSKI JOHN S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TOKARSKI JOHN S

BRISTOL MYERS SQUIBB CO

Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses

Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses

Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses

Tricyclic compounds as anticancer agents

Fused heterocyclic compounds useful as kinase modulators

Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses

Imidazotriazinecarbonitriles useful as kinase inhibitors

Sulfone pyridine alkyl amide-substituted heteroaryl compounds

Alkyl amide-substituted pyrimidine compounds useful in the modulation of IL-12, IL-23 and/or IFNα

Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses

Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses

Pyrrolotriazine compounds as kinase inhibitors

Pyrrolotriazine compounds as kinase inhibitors

Sulfone pyridine alkyl amide-substituted heteroaryl compounds

Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN-α responses

Carbazole compounds useful as bromodomain inhibitors

Heterocyclic inhibitors of kinases

Carbazole compounds useful as bromodomain inhibitors

Substituted naphthyridinone compounds useful as T cell activators

Crystallographic structure of the androgen receptor ligand binding domain

Pyrrolotriazine compounds as kinase inhibitors

Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3

Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3

Sulfone pyridine alkyl amide-substituted heteroaryl compounds

Met kinase inhibitors

Met kinase inhibitors

Substituted naphthyridinone compounds useful as T cell activators

Substituted naphthyridinone compounds useful as T cell activators

Tricyclic compounds as anticancer agents

Carbazole compounds useful as bromodomain inhibitors

Tricyclic compounds as anticancer agents

Heterocyclic inhibitors of kinases

Crystallographic structure of the androgen receptor ligand binding domain

Uracil derivatives as Mer-AXL inhibitors

WROBLESKI STEPHEN T

Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases

Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases